Every letter we have printed

A modest proposal: publish the shipping cost alongside the result. It sounds irrelevant and it is the fastest way for a reader to tell a genuine retail purchase from a sample that arrived by arrangement.

Community-funded testing has solved the money problem in a handful of cases, and it introduces a new one: the group choosing the target has its own preferences about the answer. It is a better arrangement than seller-funded testing and it is not neutral.

Reconstitution before submission destroys the custody argument entirely, and buyers do it because a solution is easier to post than a vial. The convenience is real and it converts a question about a product into a question about a preparation.

A short observation. Where an indicator has tripped, most buyers do not ask for a replacement because they assume the material is probably fine. They may well be right, and the effect is that the supplier receives no signal at all.

Ask which indicator and at what threshold. There are several products with very different trigger conditions and the carton usually says only that one is present.

Aggregation during storage is invisible to inspection and to most of what people commission afterwards. A clear solution is not evidence of an intact one, and this is the failure mode that the visual check cannot catch.

Dispatch day matters more than packaging. A parcel posted on a Thursday afternoon spends the weekend in a depot, and no amount of insulation is specified for that. Ask what day a shipment leaves, and if the answer is late in the week, ask them to hold it.

You treat aggregation as a degradation pathway alongside the chemical ones. It is worth separating, because it is physical, it is often reversible in principle and irreversible in practice, and it is the one pathway that reversed-phase chromatography will not report on at all.

Single-use indicators are much better than nothing and much weaker than a logger, because they tell you a threshold was crossed and not for how long. Ten minutes above eight degrees on a loading bay and eleven hours in a hot van produce the same red mark.

A logger recording every five minutes and a logger recording hourly will produce different excursion findings on the same journey, because the short spike at the depot falls between readings. Sampling interval is a specification and it is almost never quoted with the logger data.

You say no company reports residual moisture. I obtained a figure from a supplier last year without difficulty, on request, so the data exists in at least some cases. The problem may be less that it is not measured than that it is not printed.

Supplementation before a test produces a value that reflects the supplement rather than the status, sometimes for days. Any series that includes both supplemented and unsupplemented draws is not a series.

Assay methods for several of these differ between laboratories more than for common chemistry, and the between-method variation can exceed the width of the interval. Comparing across providers is particularly unreliable here.

Your piece assumes readers have a clinician ordering panels for them. A great many of us are buying our own, from services that supply an interval, a flag and nothing else. The apparatus you describe is not available to us at all.

The economic point is missing from your analysis. A second orthogonal determination roughly doubles the cost of knowing, and the buyers in this market are mostly individuals paying out of pocket. Recommending it without saying what it costs is the kind of advice that gets ignored rather than argued with.

Capillary electrophoresis is the forgotten answer here. It separates on charge-to-size in free solution, it needs a few nanolitres, and for anybody who already has the instrument it is an afternoon. The barrier is not cost or difficulty; it is that hardly anyone in this trade has been trained on it.

On the section about diode-array detection and peak purity, I would add that true peak purity assessment requires library matching or at least spectral comparison across the peak width. A homogeneous spectrum tells you the peak is probably pure. A spectrum that shifts across the peak tells you it is not, and that information closes a gap the article identifies correctly.

Your worked example varies gradient and threshold together and reports a 1.8-point spread. Which of the two contributed more? The article does not say, and the answer matters for what you are asking suppliers to disclose first.

One request for the checklist. Ask whether the stability data supporting the storage statement was generated on this formulation or on the same peptide in a different one. The distinction decides whether the number applies to the vial in your hand.

Arrival condition should be recorded by the buyer at the moment of opening, in writing, with a photograph. It takes a minute and it is the only record of that leg that will ever exist.

A reference interval is a description of a population, not a definition of health, and your piece is one of the few places I have seen that said so plainly. Ninety-five per cent coverage means one person in twenty who is entirely well will fall outside it on any given analyte, before anything at all has happened to them.

Biological variation is the concept I would add. Each analyte has a characteristic within-person variability, and for some of them a change has to be substantial before it means anything at all. Without that figure a delta is uninterpretable, and it is available in published tables.

Anything that shortens red cell survival lowers the result independently of glycaemia. Haemoglobin variants interfere with some assay methods and not others. These are not exotic situations, and a value that does not fit the clinical picture deserves a different measurement rather than a firmer conclusion.

Fasting glucose and glycated haemoglobin can move in opposite directions over a short period and both be correct, because they describe different windows. Your table makes that visible in a way I have not seen elsewhere and I have borrowed it for teaching.

Please repeat the exercise annually and publish the method conditions each laboratory used alongside the figures. The comparison becomes far more informative once a reader can see that the outlier ran a twelve-minute gradient and the others ran forty.

What I would fund, if I could fund anything, is a rolling blind purchase of the same molecule from the same source every quarter for three years. Longitudinal data on one line would settle more arguments than a hundred one-off determinations across the market.

Treating the four services as institutions rather than as brands is the right frame and it exposes how thin the institutional layer is. Four organisations, no common reporting standard, no shared reference material and no mechanism by which one can be compared with another except by a buyer paying twice.

As a buyer I found the section on who chose the vial genuinely clarifying and slightly deflating. I have been treating vendor-published reports as equivalent to my own submissions for two years, and on your account they are not equivalent by an amount that cannot be measured.

Colour is doing unearned work. Green reads as approved in every other context a shopper encounters, and a service that renders an ordinary numeric result in the vocabulary of a safety certification has borrowed authority it did not generate.

Constitutive activity of the receptor is measurable and rarely reported, and it changes how a partial effect should be interpreted. It is one of several parameters that would need to be held constant for any cross-paper comparison to mean anything.

Biased signalling is the part of this literature that has moved most in the last few years and is barely present in general coverage. A receptor with more than one downstream pathway can be engaged differently by two ligands with identical binding.

The half-life to steady-state arithmetic deserves to be spelled out every time, because it is the single most useful calculation in this subject. Four to five half-lives to approach steady state means a weekly molecule with a week-long half-life takes over a month, and every dose-response impression formed before then is formed on incomplete exposure.

Albumin binding as the mechanism behind the long half-life is worth expanding. The acylation is not incidental chemistry; it is the design, and it also explains why these molecules distribute the way they do. The pharmacokinetics were engineered before the clinical programme existed.

Your accumulation table gives 2.0 for a seven-day half-life at weekly dosing. I make it 2.0 as well, but I would point out that this assumes complete absorption of each dose, which for subcutaneous peptides is a generous assumption.

Prespecification matters here more than usual. A composition endpoint added after the parent results were known is a different kind of evidence from one written into the protocol, and the papers do not always make clear which they are reporting.

Where the scan schedule differed between arms for practical reasons, the comparison acquires a timing confound that no adjustment removes. It is described in the methods of at least one of these papers and never in the coverage.

What I would like from coverage of these trials is the number randomised alongside the number screened. The ratio is a statement about generalisability and it is almost never printed in a summary.

The randomised withdrawal design answers one question well and is routinely quoted as answering a different one. It tells you what happens when treatment is removed from people who reached a given point on it. It does not tell you what happens to somebody who stops for their own reasons at their own moment.

Reasons interact. Cost that would be tolerable alone becomes decisive alongside a tolerability issue that would also have been tolerable alone. Single-reason coding cannot represent this and almost all coding is single-reason.

The reporting convention that irritates me most is the pie chart. Reasons are not mutually exclusive, they are not equally weighted, and a shape that implies both is doing damage to the reader’s understanding before a single number is read.